Halozyme Therapeutics | 8-K: Current report
Apr 26 16:26 ET
Halozyme Therapeutics | DEFA14A: Others
Mar 15 16:24 ET
Halozyme Therapeutics | DEF 14A: Definitive information statements
Mar 15 16:14 ET
Halozyme Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Mar 4 16:17 ET
Halozyme Therapeutics | 8-K: HALOZYME REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL AND OPERATING RESULTS
Feb 20 16:09 ET
Halozyme Therapeutics | 8-K: Current report
Jan 17 00:00 ET
Halozyme Therapeutics | 8-K: HALOZYME REPORTS THIRD QUARTER 2023 FINANCIAL AND OPERATING RESULTS
Nov 6, 2023 16:04 ET
Halozyme Therapeutics | 8-K: Current report
Sep 7, 2023 07:14 ET
Halozyme Therapeutics | 8-K: HALOZYME REPORTS SECOND QUARTER 2023 FINANCIAL AND OPERATING RESULTS
Aug 8, 2023 16:06 ET
Halozyme Therapeutics | 8-K: HALOZYME REPORTS FIRST QUARTER 2023 FINANCIAL AND OPERATING RESULTS
May 9, 2023 16:06 ET
Halozyme Therapeutics | 8-K: Current report
May 8, 2023 16:50 ET
Halozyme Therapeutics | DEFA14A: Others
Mar 24, 2023 16:08 ET
Halozyme Therapeutics | DEF 14A: Definitive proxy statements
Mar 24, 2023 16:04 ET
Halozyme Therapeutics | 8-K: Current report
Mar 15, 2023 18:28 ET
Halozyme Therapeutics | 8-K: Current report
Mar 13, 2023 08:47 ET
Halozyme Therapeutics | 8-K: Current report
Feb 23, 2023 16:05 ET
Halozyme Therapeutics | 8-K: HALOZYME REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL AND OPERATING RESULTS
Feb 21, 2023 16:21 ET
Halozyme Therapeutics | 8-K: Current report
Feb 6, 2023 16:03 ET
Halozyme Therapeutics | 8-K: Current report
Jan 10, 2023 17:16 ET
Halozyme Therapeutics | 8-K: HALOZYME REPORTS THIRD QUARTER 2022 FINANCIAL AND OPERATING RESULTS
Nov 8, 2022 16:06 ET
No Data
No Data